Abiopharma

KAZIA THERAPEUTICS LTD (KZIA)

Symbol	KZIA
Name	KAZIA THERAPEUTICS LTD
Sector	HEALTH CARE
Region	Oceania
Industry	Pharmaceutical Preparations
Address	THREE INTERNATIONAL TOWERS LEVEL 24,, SYDNEY NSW, None 2000
Telephone	01161298780088
Fax	—
Email	—
Website	https://www.kaziatherapeutics.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001075880
Description	Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. Additional info from NASDAQ: Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

2026-04-15 12:30

KAZIA THERAPEUTICS LTD (KZIA) Files Form 6-K

2026-04-15 12:00

Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

2026-04-15 09:34

New Form 424B3 - KAZIA THERAPEUTICS LTD Filed: 2026-04-15 AccNo: 0001213900-26-043798 Size: 140 KB

2026-04-15 09:33

New Form 424B3 - KAZIA THERAPEUTICS LTD Filed: 2026-04-15 AccNo: 0001213900-26-043797 Size: 140 KB

2026-04-15 09:33

New Form 424B3 - KAZIA THERAPEUTICS LTD Filed: 2026-04-15 AccNo: 0001213900-26-043796 Size: 140 KB

2026-04-15 09:31

New Form 424B3 - KAZIA THERAPEUTICS LTD Filed: 2026-04-15 AccNo: 0001213900-26-043795 Size: 140 KB

2026-04-13 21:24

KAZIA THERAPEUTICS LTD (KZIA) Files Form 6-K

2026-04-13 21:05

Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform

2026-04-13 18:27

New Form 424B3 - KAZIA THERAPEUTICS LTD Filed: 2026-04-13 AccNo: 0001213900-26-043094 Size: 60 KB

2026-04-13 18:26

New Form 424B3 - KAZIA THERAPEUTICS LTD Filed: 2026-04-13 AccNo: 0001213900-26-043090 Size: 60 KB

Trial ID	Title	Phase	Indication	Status	Start Date	Completion Date	Source
NCT04192981	GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brai…	Phase1	Brain Metastases	Active_Not_Recruiting	2019-12-06	2026-12-01	ClinicalTrials.gov

Total clinical trials: 1

Product Name	Type	Development Stage	Therapeutic Area	Study Status	Trial ID
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
whole brain radiation therapy radiation	Drug	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981
GDC-0084	Other	Phase PHASE1	Brain Metastases	ACTIVE_NOT_RECRUITING	NCT04192981

Total products: 18